{"id":3968,"date":"2021-11-03T13:25:41","date_gmt":"2021-11-03T13:25:41","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=3968"},"modified":"2021-11-03T13:30:27","modified_gmt":"2021-11-03T13:30:27","slug":"enyo-pharma-annonce-deux-presentations-de-donnees-sur-vonafexor-lors-de-la-conference-aasld-the-liver-meeting","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-annonce-deux-presentations-de-donnees-sur-vonafexor-lors-de-la-conference-aasld-the-liver-meeting\/","title":{"rendered":"Â鶹Æƽâ°æ Annonce Deux Pr\u00e9sentations de Donn\u00e9es sur Vonafexor lors de la Conf\u00e9rence AASLD The Liver Meeting"},"content":{"rendered":"

Lyon, France. 3 Novembre 2021 – Â鶹Æƽâ°æ (ENYO), une soci\u00e9t\u00e9 priv\u00e9e de biotechnologie au stade clinique et d\u00e9veloppant des candidats-m\u00e9dicaments innovants, a annonc\u00e9 aujourd\u2019hui que deux abstracts sur Vonafexor avaient \u00e9t\u00e9 accept\u00e9s, l’un sous forme de pr\u00e9sentation orale et l’autre sous forme de poster, pour de la prochaine conf\u00e9rence 2021 The Liver Meeting\u00ae, organis\u00e9e par l’AASLD du 12 au 15 Novembre 2021.<\/p>\n <\/span>T\u00e9l\u00e9charger le communiqu\u00e9 de presse (PDF)<\/span><\/a> \n","protected":false},"excerpt":{"rendered":"

Lyon, France. 3 Novembre 2021 – Â鶹Æƽâ°æ (ENYO), une soci\u00e9t\u00e9 priv\u00e9e de biotechnologie au stade clinique et d\u00e9veloppant des candidats-m\u00e9dicaments innovants, a annonc\u00e9 aujourd\u2019hui que deux abstracts sur Vonafexor avaient \u00e9t\u00e9 accept\u00e9s, l’un sous forme de pr\u00e9sentation orale et l’autre sous forme de poster, pour de la prochaine conf\u00e9rence 2021 The Liver Meeting\u00ae, organis\u00e9e par l’AASLD du 12 au 15 Novembre 2021.<\/p>\n

Lire la suite »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-3968","post","type-post","status-publish","format-standard","hentry","category-press-releases-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"Press releases<\/a>","rttpg_excerpt":"Lyon, France. 3 Novembre 2021 – Â鶹Æƽâ°æ (ENYO), une soci\u00e9t\u00e9 priv\u00e9e de biotechnologie au stade clinique et d\u00e9veloppant des candidats-m\u00e9dicaments innovants, a annonc\u00e9 aujourd\u2019hui que deux abstracts sur Vonafexor avaient \u00e9t\u00e9 accept\u00e9s, l’un sous forme de pr\u00e9sentation orale et l’autre sous forme de poster, pour de la prochaine conf\u00e9rence 2021 The Liver Meeting\u00ae, organis\u00e9e…","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3968"}],"version-history":[{"count":4,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3968\/revisions"}],"predecessor-version":[{"id":3978,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3968\/revisions\/3978"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}